Publicaciones en las que colabora con NURIA ERITJA SANCHEZ (16)

2024

  1. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

2023

  1. Molecular Pathology of Endometrial Tumors

    Molecular Surgical Pathology: Second Edition (Springer International Publishing), pp. 297-321

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2020

  1. Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study

    Histopathology, Vol. 76, Núm. 3, pp. 447-460

2019

  1. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    Virchows Archiv, Vol. 474, Núm. 5, pp. 585-598

  2. Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85

2018

  1. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology, Vol. 85, Núm. 1-2, pp. 35-40

2017

  1. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy, Vol. 13, Núm. 3, pp. 608-624

  2. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164

  3. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026

2016

  1. Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood, Vol. 127, Núm. 15, pp. 1907-1911

  2. Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias

    European Journal of Cancer, Vol. 63, pp. 74-87

  3. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374

  4. Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 4, pp. 526-535

2013

  1. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias

    DMM Disease Models and Mechanisms, Vol. 6, Núm. 3, pp. 710-720